Result of AGM
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Result of AGM
Omega (AIM: ODX), the medical diagnostics company focused on Global Health (CD4 and COVID-19) and Health and Nutrition, announces that all resolutions were duly passed at the Annual General Meeting held earlier today.
The results are set out below:
Resolution | For | Against | Discretion to Chairman | Withheld | Total |
1 | 9,374,684 | 23,021 | 32,985 | 88,420 | 9,519,110 |
2 | 9,421,626 | 59,735 | 32,985 | 4,764 | 9,519,110 |
3 | 5,015,063 | 4,138,825 | 32,985 | 332,237 | 9,519,110 |
4 | 5,095,359 | 358,971 | 32,985 | 4,031,795 | 9,519,110 |
5 | 8,514,388 | 963,219 | 32,985 | 8,518 | 9,519,110 |
6 | 8,430,095 | 1,047,954 | 32,985 | 8,076 | 9,519,110 |
Contacts:
Omega Diagnostics Group PLC | www.omegadiagnostics.com |
Colin King, Chief Executive | via Walbrook PR |
Chris Lea, Chief Financial Officer | |
finnCap Ltd | Tel: 020 7220 0500 |
Geoff Nash/Edward Whiley (Corporate Finance) | |
Alice Lane/ Charlotte Sutcliffe (ECM) | |
Walbrook PR Limited | Tel: 020 7933 8780 or [email protected] |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.